HoneyBear Biosciences and A*STAR Team Successfully Complete Two Licensing Agreements in Singapore Read more
Dr. Chuang, Simon, Shih-Hsien, CEO of HoneyBear Biosciences, invited to give a speech at ADC Congress Asia Read more
Special Interview on Startup 101—"Next-Generation Cancer Drug Platform, Becoming a Lifeline for Patients: Interview with HoneyBear Biosciences" Read more
“Process For Preparing Glycoprotein-Drug Conjugates”awarded with Silver award of the 8th National invention and creation award granted by Ministry of Economic Affairs. Read more
Simon Shih-Hsien Chuang, CEO of Honeybear Biosciences invited to give a speech in 2023 BioAsia Read more
“First ADC drug with dual anti-cancer effects worldwide” press conference on March 13th, 2023 Read more
